» Authors » Gaurav Kaushik

Gaurav Kaushik

Explore the profile of Gaurav Kaushik including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 73
Citations 1434
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Khan I, Kaushik G, Verma C, Vashishtha R, Kumar V
Nanotechnol Sci Appl . 2024 Dec; 17:247-258. PMID: 39703561
Introduction: Efficient extraction of DNA from biological fluids is crucial for applications in molecular biology, forensic science, and clinical diagnostics. However, traditional DNA extraction methods often require costly reagents and...
2.
Khan N, Verma C, Ali Beg M, Kumar S, Kaushik G, Ahmad H, et al.
Immunotargets Ther . 2024 Dec; 13:691-705. PMID: 39678140
Background: CD4+ cells, HIV-1 plasma viral load (PVL), and IFN-γ have been observed to enhance susceptibility in TB infection/reactivation among HIV-1 infected people, leading to unusual clinical manifestations. HIV-TB co-infection...
3.
Kaushik G, Vashishtha R, Verma C, Sharma S, Kumar V
J Inflamm Res . 2024 May; 17:3283-3291. PMID: 38800599
Background: Toll-like receptors (TLRs) are identified as one of the key components of the innate immune system. The objective of this study was to explore the influence of genetic variability...
4.
Patel S, Patel M, Kaushik G, Patel M, Desai J, Patel M
Int J Pharm Compd . 2024 May; 28(3):249-259. PMID: 38768505
Since ancient times, mouth fresheners in many different forms have been used throughout the world. Traditional knowledge describes the health benefits of mouth fresheners, and contemporary science is now investigating...
5.
Stresser D, Kopec A, Hewitt P, Hardwick R, Van Vleet T, Mahalingaiah P, et al.
Nat Biomed Eng . 2023 Dec; 8(8):930-935. PMID: 38151640
No abstract available.
6.
Verma C, Pawar V, Srivastava S, Tyagi A, Kaushik G, Shukla S, et al.
Vaccines (Basel) . 2023 Dec; 11(12). PMID: 38140187
Therapeutic vaccines are a promising alternative for active immunotherapy for different types of cancers. Therapeutic cancer vaccines aim to prevent immune system responses that are not targeted at the tumors...
7.
Kaushik G, Vashishtha R
Int J Mycobacteriol . 2023 Mar; 12(1):10-16. PMID: 36926756
Background: It has been demonstrated that toll-like receptors (TLR2), TLR4, and TLR9 which were initially known for recognizing bacterial products are involved in the detection of viral components. It was...
8.
Kaushik G, Patel M
Microbiol Resour Announc . 2023 Feb; 12(3):e0121222. PMID: 36728433
Weizmannia coagulans MB BCM9 (MTCC 25157) is a safe probiotic strain. Here, we announce a fully assembled draft genome sequence consisting of 3,450,803 bp, with 139 contigs. A total of...
9.
Kaushik G, Vashishtha R
Int J Mycobacteriol . 2022 Oct; 11(3):293-298. PMID: 36260448
Background: Gene expression levels of TLRs (TLR2, TLR4 and TLR9) are directly involved in the virus recognition and initiation of innate immune responses, therefore, the effect of HIV infection on...
10.
Yadav R, Verma A, Kaushik G
J Glob Infect Dis . 2022 Oct; 14(3):93-98. PMID: 36237568
Introduction: Tuberculosis (TB) remains a deadliest infectious disease. Lack of rapid test with low cost is one of the important challenges to eradicate the TB. The objective of the study...